Lapatinib in Combination With Docetaxel in Patients With HER-2 Positive Advanced or Metastatic Breast Cancer
Status: COMPLETED
Study type: INTERVENTIONAL
Conditions: Metastatic Breast Cancer
Interventions: DRUG: lapatinib|DRUG: docetaxel
Sponsor: Centre Georges Francois Leclerc
Collaborators: GlaxoSmithKline|Sanofi